As demands for diversity and equity increase across the globe, a new analysis finds nearly 75% of patients who are enrolled in industry-sponsored clinical trials in academic medical centers and community hospitals are white.
Yet the proportion of a given race or ethnicity among clinical trial personnel closely aligns with the corresponding race or ethnicity of study participants, according to the Center for Study of Drug Development at Tufts University, which conducted the analysis of nearly 3,200 trial sites that are regulated by the Food and Drug Administration. Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. What’s included? Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. This name will appear with your comment
https://www.statnews.com/pharmalot/2021/11/05/clinical-trials-diversity-inclusion/
